Home

Abbott Laboratories (ABT)

128.11
+4.14 (3.34%)
NYSE · Last Trade: Nov 22nd, 1:06 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Via StockStory · November 21, 2025
Top 2 Healthcare Stocks Every New Investor Should Knowfool.com
These healthcare stocks have long-term and profitable growth runways.
Via The Motley Fool · November 21, 2025
2 Fantastic Dividend Stocks to Buy and Hold Foreverfool.com
These companies have been raising their payouts for a combined 101 consecutive years.
Via The Motley Fool · November 21, 2025
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profitsstocktwits.com
Via Stocktwits · November 20, 2025
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeoverstocktwits.com
Via Stocktwits · November 20, 2025
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & Morefool.com
On a big day for tech stocks, some other less well-known companies saw even larger moves.
Via The Motley Fool · November 20, 2025
Why Exact Sciences Rallied Over 50% This Weekfool.com
The company received a buyout offer from Abbot Labs.
Via The Motley Fool · November 20, 2025
Why Exact Sciences Stock Surged Todayfool.com
A healthcare giant covets the cancer screening leader's technology.
Via The Motley Fool · November 20, 2025
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's stronger-than-expected second-quarter fiscal 2026 earnings report, which showcased robust performance driven by key segments and innovative technology.
Via MarketMinute · November 20, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · November 20, 2025
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnosticsbenzinga.com
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.
Via Benzinga · November 20, 2025
Abbott To Acquire Exact Sciences For Up To $23Bstocktwits.com
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.
Via Stocktwits · November 20, 2025
Why Exact Sciences Stock Blasted Nearly 24% Higher Todayfool.com
A strategic investor is reportedly in advanced talks to purchase the company.
Via The Motley Fool · November 19, 2025
2 Healthcare Stocks Worth Your Attention and 1 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 7.4% return has trailed the S&P 500 by 3.6 percentage points.
Via StockStory · November 19, 2025
2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Incomefool.com
Dividend stocks can strengthen your portfolio during any market environment.
Via The Motley Fool · November 15, 2025
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.fool.com
These stocks pay income that investors can count on over the long run.
Via The Motley Fool · November 15, 2025
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an uncertain economic landscape. While specific real-time data for this future date is beyond current predictive capabilities, an analysis of the sector's
Via MarketMinute · November 14, 2025
What Does the Market Think About Abbott Laboratories?benzinga.com
Via Benzinga · November 14, 2025
Chicago Fed's 7th District Hiring Expectations Crash to -40: A Dire Signal for the Economy and Fed Policy
The economic outlook for the U.S. Midwest has taken a concerning turn as the Chicago Federal Reserve's 7th District hiring expectations index reportedly plummeted to -40 in October 2025. This alarming figure represents the lowest reading for hiring expectations since the tumultuous year of 2020 and, excluding the pandemic
Via MarketMinute · November 10, 2025
2 Top Dividend Stocks to Buy and Hold Foreverfool.com
These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.
Via The Motley Fool · November 10, 2025
Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility
Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly technology, have propelled major U.S. and Canadian indices to new heights, a closer look reveals a landscape of mixed results, with individual company
Via MarketMinute · November 7, 2025
Q3 Earnings Outperformers: Abbott Laboratories (NYSE:ABT) And The Rest Of The Medical Devices & Supplies - Diversified Stocks
Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Abbott Laboratories (NYSE:ABT) and its peers.
Via StockStory · November 3, 2025
Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts
The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers' Index (PMI). From late 2024 through November 2025, these barometers of economic health have signaled a period of deliberate rebalancing, characterized
Via MarketMinute · November 5, 2025
AI's Power Problemfool.com
AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast?
Via The Motley Fool · November 3, 2025
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beatmarketbeat.com
Via MarketBeat · November 1, 2025